Expand SLRN Menu
SLRN MENU

SLRN Stock Posts


Upcoming Earnings

SLRN Acelyrin5.95+0.07 (+1.2%)

Acelyrin will report earnings after the market closes. View Calendar The market is expecting a ±5.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.4%. View Expected Move (Conf Call: Nov 13 4:30 PM)
SLRN #Acelyrin stock increases 11.3% after hours.

After Hours Gainer

SLRN Acelyrin4.76+0.20+4.4%

After Hours:5.30+0.54 (+11.3%)

ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa; Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results

Globe NewswireTue, 13-Aug 4:00 PM
Upcoming Earnings

SLRN Acelyrin4.41-0.15 (-3.3%)

Acelyrin will report earnings after the market closes. View Calendar The market is expecting a ±24.9% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±4.6%. View Expected Move (Conf Call: Aug 13 5:00 PM)
Upcoming Earnings

SLRN Acelyrin4.85+0.17 (+3.6%)

Acelyrin will report earnings after the market closes. View Calendar The market is expecting a ±8.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±4.9%. View Expected Move (Conf Call: May 13 4:30 PM)
Unusual Option Volume

SLRN Acelyrin6.53-0.22 (-3.3%)

Acelyrin trades 2,975 contracts. News: ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights
View Details...
Unusual Option Volume

SLRN Acelyrin8.32+0.84 (+11.2%)

Acelyrin trades 8,009 contracts. News: ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis
View Details...
Load Earlier Posts